Abstract
Malaria is transmitted by protozoan parasites of the Plasmodium genus, via mosquito vectors. Highly effective vaccines could be a valuable tool to control the disease, but have remained elusive, in part due to the complex lifecycle of the parasite. Transmission-blocking vaccines (TBVs) take the unconventional approach of targeting the mosquito stages of the parasite life cycle. TBVs are yet to be tested in large-scale human trials, but represent a prominent area of interest for malaria vaccine research and development. Because TBVs rely on passive antibody transfer from a blood meal to the mosquito midgut, techniques to boost host antibody generation are a focus of investigation. In this review, immunostimulants and delivery systems for conjugating, self-assembling, or coadministrating TBV antigens and adjuvants are summarized.
| Original language | English |
|---|---|
| Article number | 1800011 |
| Journal | Advanced Biosystems |
| Volume | 2 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2018 |
Keywords
- adjuvants
- antigens
- malaria
- transmission-blocking
- vaccines
Fingerprint
Dive into the research topics of 'Adjuvant and Antigen Systems for Malaria Transmission-Blocking Vaccines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver